The Mission Marketing Share Discussion Threads

[cheshire man] 23/7/2015 10:34

Smart looking chart :-)

[chinese investor] 23/7/2015 10:20

Go Horsey !

[18bt] 23/7/2015 07:46

New Edison note:

The mission’s trading update shows the group on track to meet full-year market expectations, with the normal profits’ bias towards the second half. This has been a busy time for the group, now firmly on the front foot as it seeks out and consolidates opportunities for both organic and acquisitional growth. With continued strengthening of the balance sheet and forecast EPS growth of 10% in the current year and 9% in FY16, the rating of 7.2x FY15 is on an overly heavy discount to peers and markets.

[chinese investor] 22/7/2015 16:04

Looking Good !

[dr biotech] 22/7/2015 15:37

Well a decent reaction this afternoon. Not enough to stop me having a down day, but certainly covers most of my losses. Would like to see this be properly rerated to a double figure PE...

[cheshire man] 22/7/2015 13:25

Making all the right moves IMO, happy to hold :-) DYOR

Revenue and profit for the first half of 2015 are expected to show double digit growth over the equivalent period last year, benefiting from both organic growth and the acquisitions made in the second half of last year. The group's net debt fell from GBP9.4m at 31 December 2014 to GBP8.3m at 30 June 2015, and the group's leverage ratios (the ratios of net bank debt and total debt to EBITDA) remain comfortably within the limits set by the Board for these key performance indicators.

The group has made five acquisitions over the last twelve months, merged two of its existing Integrated Generalist Agencies and launched a new Specialist Agency from scratch. It has been a busy time and our recent focus has been on bedding these new businesses into the group. Looking to the future, we will seek to exploit the opportunities for further growth these new businesses bring and in addition we will continue to explore opportunities to extend our range and reach further in response to Client demand.

Our results for the year to 31 December 2015 are again expected to have a bias towards the second half and the Board remains confident of meeting market expectations for the full year.

[dr biotech] 22/7/2015 07:31

Decent enough update today, growth at least 10%. Have to wonder why this one seems to be consistently overlooked.

[cheshire man] 17/7/2015 13:28

Sitting on support now, some decent sized buy's today and TU any day!

[paulturner006] 09/7/2015 08:14

When do we go Xd?

[dr biotech] 02/7/2015 15:50

Last couple of years have seen trading updates on the 14/18 July. So hopefully next couple of weeks. We also go xd this time next week - this co has to have one of the longest times between the div announcement and the xd date.

[interceptor2] 01/7/2015 07:58

News of a new division (Mongoose) today, link below to launch video. Should be a trading update soon, they normally release one in mid July.

[paulturner006] 26/6/2015 12:12

What's happening here with SP?

[fillipe] 01/6/2015 15:04

Finncap 29-5-15 CORP.

2015 eps 5.6p and 1.2p of div.
2016 6.1p and 1.3p

It's only a matter of time before folks start to really appreciate this one.

f

[dr biotech] 01/6/2015 13:45

46p seems to be a bit of a glass ceiling with this one. Perhaps it will be third time lucky. Still a long term hold for me.

[cheshire man] 01/6/2015 13:23

Chart turning in the right direction today :-)

[cheshire man] 28/4/2015 08:59

A few buyer's coming in I see :-)

[interceptor2] 08/4/2015 09:17

Thank you GHF for the Finncap note, and I remember seeing your informative write up on the zulu thread, infact there was a positive article last week in Investors Chronicle.

Judging by the positive recent share price move on modest buying, agree that any overhang has now cleared.

[dasv] 07/4/2015 14:53

thanks GHF

[glasshalfull] 02/4/2015 19:57

Well, since I posted my summary of the investment case in January there's been a lot more traffic on the thread. Good to see a number of quality investors have also come to the conclusion that there's significant value here.

I've been an infrequent poster but thought you'd be interested in finnCap's update issued last week.

"The final results were in line with forecast and our two-year forecasts imply PBT growth of 27%. Despite that, the group sits at a significant discount to its peer group, for which we see little justification.

The final results were in line with forecast in almost every respect. Operating income (the group's equivalent to revenue) increased by 7% in the year to £55.0m compared with the finnCap forecast of £54.4m. Headline PBT was £5.53m, 10% up year-on-year and compared with our £5.50m forecast.
Net debt was reduced further by £1.3m to £9.4m despite capital expenditure and acquisition investment of £4.2m. The group has also recently agreed a four-year extension to its facilities at better rates and has also repaid £0.7m of bank warrants in full. During the year, the group's leverage ratio fell further from 1.5x to 1.25x.

The group made three acquisitions in the year: Proof Communication, Splash and Speed Communications. It also created a Sports Marketing consultancy and relocated both April Six and ThinkBDW to new premises to facilitate further growth. Internationally, the Splash acquisition has further consolidated the group's presence in Singapore and provided a presence in five other Far Eastern markets. The new San Francisco April Six agency is also reported to have started well. So far in 2015, the group has announced one further small acquisition (Weather Digital) and integrated the Big and balloon dog agencies under the bigdog brand.

Following the results, our 2015 forecast remains unchanged and we have introduced a 2016 forecast which implies two-year PBT growth of 27%. Our peer group analysis confirms that Mission Marketing is trading at a discount to the average of its peer group of c.60% on an EV/Sales basis, 15% on an EV/EBITDA basis and 30% on a PE basis. We do not see any justification for this and retain our 60p share price target."

I agree & have been a recent buyer. Hopefully the shareprice overhang has now cleared.

Happy Easter everyone!


Kind regards,
GHF

[dasv] 02/4/2015 14:25

FWIW I've been in since Jan 27th. A value/growth play in my opinion.

[battlebus2] 02/4/2015 11:25

Well done holders , mistimed my purchase here doh!!

[joe say] 02/4/2015 09:38

Glad to see the market waking up to this one

[dr biotech] 02/4/2015 09:34

Some well timed director buys. They seem to have given more confidence than the results.

Hopefully this will rise to meet the sector average PE. Its my largest small cap by some distance.